Filing Details
- Accession Number:
- 0001127602-13-006944
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-20 11:48:49
- Reporting Period:
- 2013-02-15
- Filing Date:
- 2013-02-20
- Accepted Time:
- 2013-02-20 11:48:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1456336 | Gregory Stea | 65 Hayden Avenue Lexington MA 02421 | Svp, Commercial Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-16 | 1,600 | $0.00 | 11,847 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-19 | 611 | $41.40 | 11,236 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Restricted Stock Units | Acquisiton | 2013-02-15 | 5,889 | $0.00 | 5,889 | $0.00 |
| Common Stock | Stock Options (Right to Buy) | Acquisiton | 2013-02-15 | 36,072 | $0.00 | 36,072 | $41.60 |
| Common Stock | Restricted Stock Units | Acquisiton | 2013-02-15 | 5,889 | $0.00 | 5,889 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2013-02-16 | 1,600 | $0.00 | 1,600 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,889 | 2016-02-15 | No | 4 | A | Direct | |
| 36,072 | 2013-05-15 | 2023-02-15 | No | 4 | A | Direct |
| 5,889 | 2014-02-15 | No | 4 | A | Direct | |
| 4,800 | 2013-02-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 153 | Indirect | 401(k) Plan |
Footnotes
- Sold pursuant to a Rule 10(b)5-1 Plan.
- Shares were sold to cover tax obligations incurred in connection with the vesting of Restricted Stock Units.
- This transaction was executed in multiple trades at prices ranging from $41.4000 to $41.4050. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
- Shares are earned based on the achievement of certain performance conditions, which are set forth in the applicable performance unit agreement. Any earned shares are delivered to the reporting person on the third anniversary of the grant date. The restricted stock units do not expire.
- Option vests 6.25% quarterly over a four-year period.
- Each restricted stock unit represents a contingent right to receive one share of Cubist common stock for no consideration.
- The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.
Billionaire Hedge Funds
